
    
      This is a randomized prospective study with 2 arms to evaluate the efficacy of Levofloxacin
      prophylaxis in Azacytidine treated patients (MDS and AML) Levofloxacin will be given 500mg/d
      p.o. for the first three cycles of Azacytidine in patients randomized in arm antibacterial
      prophylaxis. In control arm patients will not received levofloxacin.

      The expected duration of subject participation is one year after randomization.
    
  